European Archives - Page 421 of 1017 - European Medical Journal

Identifying Common Biomarkers Between COVID-19 and Commonly Associated Comorbidities

The recent COVID-19 pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and, since its…

Current Therapy for Homozygous Familial Hypercholesterolaemia

Homozygous familial hypercholesterolaemia (HoFH) is a rare and aggressive disorder, resulting from the inheritance of mutations in the two alleles of genes regulating the low-density lipoprotein receptor (LDL-R) function.

Risk Factors and Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis: An Update

The therapeutic technique of endoscopic retrograde cholangiopancreatography (ERCP) has evolved as a therapeutic endoscopic technique for…

Cefixime-Induced Hepatitis: A Case Report and Review of Literature

Cephalosporins, a family of bactericidal antibiotics, have side effects like penicillin due to the similarity in their basic structure…

The biotech boom: fad or forever?

Biotechs have stood as agile hubs for drug discovery, but now they are being coveted by investors.

Standing out in a crowd of digital content

The amount of digital content being created for healthcare professionals has grown exponentially. Medical affairs teams must find a way to cut through the noise with their communications

A cautionary tale of digital transformation

As the pharmaceutical industry embraces digital transformation, new technologies have the potential to sink or swim. How can the industry ensure it’s backing the most effective innovations and not getting stuck in dead ends?

The future of pharmaceutical sales

The COVID-19 pandemic has reshaped pharmaceutical sales, moving from face-to-face to predominantly digital interactions. How can sales reps adapt to multichannel approaches and enhance performance amidst this shift in sales training and team dynamics?

In data we trust: how to nail consent and preference management

The pharmaceutical industry’s digital transformation during the pandemic has fuelled fresh opportunities to collect and harness data, but this venture must be approached with a strong consideration for consent and preference management rules

EMJ Hematology 9 [Supplement 6] 2021

Presentations on sickle cell disease (SCD) at the European Hematology Association (EHA) Virtual Congress 2021.